Your email has been successfully added to our mailing list.

×
0.0144927536231886 0.0144927536231886 0.0144927536231886 0.0144927536231886 0.0217391304347828 1.60901887626834E-16 1.60901887626834E-16 1.60901887626834E-16
Stock impact report

Alimera Sciences To Expand ILUVIEN® Indication in Europe for Posterior Uveitis

Alimera Sciences, Inc. (ALIM) 
Last alimera sciences, inc. earnings: 4/29 04:00 pm Check Earnings Report
Company Research Source: GlobeNewswire
Converts existing ILUVIEN profit share arrangement to royalty agreementNo upfront cash paymentAlimera Sciences plans to file ILUVIEN for posterior uveitis indication in 17 EU countries within 8 monthspSivida to withdraw centralized EU application for posterior uveitis ATLANTA, July 10, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that it secured the rights to pursue posterior uveitis, a secondary indication for ILUVIEN, in the European Union (EU), the Middle East and Africa.  Alimera secured the rights by signing a Second Amended and Restated Collaboration Agreement (the New Collaboration Agreement) with pSivida, US, Inc. (pSivida), a subsidiary of pSivida Corporation (NASDAQ:PSDV). The New Collaboration Agreement amends and restates the previous agreement entered into between the parties. Under the previous agreement, Alimera held the worldwid Show less Read more
Impact Snapshot
Event Time:
ALIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ALIM alerts
Opt-in for
ALIM alerts

from News Quantified
Opt-in for
ALIM alerts

from News Quantified